[Molecular diagnostics in neuropathology]

W Dietmaier1, J Lorenz, M J Riemenschneider

  • 1Institut für Pathologie, Zentrum für molekularpathologische Diagnostik, Universität Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Deutschland, Wolfgang.Dietmaier@ukr.de.

Der Pathologe
|March 31, 2015
PubMed
Summary

Molecular markers are crucial for brain tumor treatment decisions, driving research into tumor development and personalized therapies. Integrating this knowledge into clinical practice requires multidisciplinary collaboration for better patient outcomes.